The best indicator for Universal Health Services (UHS)
We backtested 20 indicators across daily, weekly and hourly charts on real Universal Health Services (UHS) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
CCI
On the weekly chart, this is the strongest risk-adjusted edge we found for Universal Health Services (UHS) over ~45.1 years — trailing buy-and-hold by 2.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | CCI ✓ | Weekly | 9.0% | 0.53 | -49.4% | 88.4% | 43 | -2.5% |
| 2 | RSI Trend (>50) ✓ | Daily | 10.1% | 0.51 | -69.6% | 37.8% | 579 | -1.4% |
| 3 | ADX / DMI ✓ | Daily | 8.8% | 0.51 | -41.3% | 38.8% | 291 | -2.7% |
| 4 | Donchian Breakout ✓ | Daily | 8.6% | 0.49 | -50.3% | 46.2% | 173 | -2.8% |
| 5 | MACD ✓ | Weekly | 9.6% | 0.49 | -63.6% | 54.0% | 87 | -1.9% |
| 6 | EMA-10 Trend ✓ | Weekly | 9.5% | 0.48 | -73.0% | 50.3% | 191 | -2.0% |
| 7 | MACD ✓ | Daily | 9.2% | 0.47 | -65.9% | 44.3% | 422 | -2.3% |
| 8 | Williams %R ✓ | Weekly | 8.3% | 0.46 | -52.6% | 81.7% | 60 | -3.2% |
| 9 | Rate of Change ✓ | Daily | 8.5% | 0.45 | -57.0% | 42.4% | 734 | -2.9% |
| 10 | Rate of Change ✓ | Weekly | 8.5% | 0.45 | -68.8% | 43.9% | 132 | -3.0% |
| 11 | EMA 20/50 Cross ✓ | Daily | 8.2% | 0.44 | -72.1% | 39.4% | 99 | -3.2% |
| 12 | Donchian Midline ✓ | Daily | 8.4% | 0.44 | -77.9% | 41.2% | 597 | -3.1% |
| 13 | Heikin-Ashi Trend ✓ | Weekly | 8.2% | 0.44 | -49.1% | 47.0% | 415 | -3.3% |
| 14 | Donchian Midline ✓ | Weekly | 7.9% | 0.43 | -75.8% | 42.6% | 115 | -3.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Universal Health Services (UHS), CCI on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.